Retrospective cohort study examines the impact of AST/ALT ratio on mortality in patients with severe acute pancreatitis, suggesting prognostic value.
Patients with acute pancreatitis (AP) in the intensive care unit experience high complication and mortality rates, making early prognosis prediction crucial. While the aspartate aminotransferase to alanine aminotransferase (AST/ALT) ratio is correlates with prognosis in various diseases, its association with mortality in severe AP remains uncertain. AP patients were identified using the Medical Information Mart for Intensive Care-IV database. Cox proportional hazard regression models examined the link between the AST/ALT ratio and 365-day mortality. Kaplan-Meier survival curve analysis was conducted to assess patient survival across AST/ALT ratio quartiles. restricted cubic splines analysis determined the relationship curve between 365-day mortality and the AST/ALT ratio level. We also conducted subgroup analyses to assess the robustness of the findings. A total of 817 patients were included in this retrospective cohort study. After adjusting for all covariates, the Cox regression model showed that the AST/ALT ratio was positively associated with 365-day mortality in patients with AP (hazard ratio: 1.33, 95% confidence interval: 1.16-1.52). When the AST/ALT ratio was divided into 4 groups based on quartiles, participants in the Q4 group had a significantly higher mortality compared with Q1 (hazard ratio:2.11, 95% confidence interval: 1.30-3.40). The Kaplan-Meier curves showed that patients in the Q1 group had the lowest mortality (log-rank P < .001). The restricted cubic splines curve indicated a linear relationship between the AST/ALT ratio and mortality in AP patients (P for nonlinear > .05). Subgroup analyses further demonstrated that this association was more pronounced in men. Finally, the AST/ALT ratio improved the predictive performance of sequential organ failure assessment score for mortality in patients with AP. In critically ill AP patients, a higher AST/ALT ratio on admission was associated with greater 365-day mortality, especially in males. It is suggested that the AST/ALT ratio can be used as a simple and effective prognostic marker for patients with severe AP.
No takes yet. Share an insight, caveat, or question.
Zhimin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: